Literature DB >> 10794694

Design of a Gag pentapeptide analogue that binds human cyclophilin A more efficiently than the entire capsid protein: new insights for the development of novel anti-HIV-1 drugs.

Q Li1, M Moutiez, J B Charbonnier, K Vaudry, A Ménez, E Quéméneur, C Dugave.   

Abstract

Cyclophilin A (hCyp-18), a ubiquitous cytoplasmic peptidyl-prolyl cis/trans isomerase (PPIase), orchestrates HIV-1 core packaging. hCyp-18, incorporated into the virion, enables core uncoating and RNA release and consequently plays a critical role in the viral replication process. hCyp-18 specifically interacts with a single exposed loop of the Gag polyprotein capsid domain via a network of nine hydrogen bonds which mainly implicates a 7-mer fragment of the loop. As previously reported, the corresponding linear heptapeptide Ac-Val-His-Ala-Gly-Pro-Ile-Ala-NH(2) (2) binds to hCyp-18 with a low affinity (IC(50) = 850 +/- 220 microM) but a potentially useful selectivity for hCyp-18 relative to hFKBP-12, another abundant PPIase. On the basis of X-ray structures of Gag fragments:hCyp-18 complexes, we generated a series of modified peptides in order to probe the determinants of the interaction and hence to select a peptidic ligand displaying a higher affinity than the capsid domain of Gag. We synthesized a series of heptapeptides to test the energetic contribution of amino acids besides the Gly-Pro moiety. In particular the importance of the histidine residue for the interaction was underscored. We also investigated the influence of N- and C-terminal modifications. Hexapeptides containing either deaminovaline (Dav) in place of the N-terminal valine or substitution of the C-terminal alanine amide with a benzylamide group displayed increased affinities. Combination of both modifications gave the most potent competitor Dav-His-Ala-Gly-Pro-Ile-NHBn (28) which has a higher affinity for hCyp-18 (K(d) = 3 +/- 0.5 microM) than the entire capsid protein (K(d) = 16 +/- 4 microM) and a very low affinity for hFKBP-12. Some of our results strongly suggest that the title compound is not a substrate of hCyp-18 and interacts preferentially in the trans conformation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10794694     DOI: 10.1021/jm9903139

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  3 in total

1.  A convenient approach to synthesizing peptide C-terminal N-alkyl amides.

Authors:  Wei-Jie Fang; Tatyana Yakovleva; Jane V Aldrich
Journal:  Biopolymers       Date:  2011-02-09       Impact factor: 2.505

2.  Refinement and 3D-QSAR Studies of Inhibitors of Cyclophilin A Containing Amide Linker.

Authors:  Feng Fan; Jin Zhu; Shuaishuai Ni; Jiagao Cheng; Yun Tang; Congmin Kang; Jian Li; Hualiang Jiang
Journal:  QSAR Comb Sci       Date:  2008-11-28

3.  Discovery of novel low-molecular-weight HIV-1 inhibitors interacting with cyclophilin A using in silico screening and biological evaluations.

Authors:  Yu-Shi Tian; Chris Verathamjamras; Norihito Kawashita; Kousuke Okamoto; Teruo Yasunaga; Kazuyoshi Ikuta; Masanori Kameoka; Tatsuya Takagi
Journal:  J Mol Model       Date:  2012-09-05       Impact factor: 1.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.